Thompson Siegel & Walmsley LLC Edwards Lifesciences Corp Transaction History

Thompson Siegel & Walmsley LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $1.06 Million - $1.43 Million	-15,300 Reduced 99.9%	15 $1,000
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $1.25 Million - $1.44 Million	15,300 Added 102000.0%	15,315 $1.45 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $1,024 - $1,311	15 New	15 $1,000
Q1 2021 May 07, 2021	BUY	$78.68 - $90.67 $1,180 - $1,360	15 New	15 $1,000
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $4,612 - $7,128	-88 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$71.7 - $82.09 $1,075 - $1,231	15 Added 20.55%	88 $21,000
Q3 2017 Nov 08, 2017	SELL	$36.29 - $38.83 $15,423 - $16,502	-425 Reduced 85.34%	73 $8,000
Q2 2017 Aug 09, 2017	BUY	N/A	498	498 $59,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.